Journal of Psychiatry

Continuous circular cycling in Bipolar disorder as a predictor of poor outcome

Euro Global Summit and Medicare Expo on Psychiatry

July 20-22, 2015 Barcelona, Spain

Rocco de Filippis

Scientific Tracks Abstracts: J Psychiatry

Abstract:

Objective: This prospective study aims to determine if patients with bipolar disorder with a continuous circular course (CCC) are significantly different in clinical characteristics and response to long- term treatment from those with a non-continuous circular course (N-CCC). CCC was defined as the alternation of depression and (hypo)mania without a completely free well interval, and N-CCC as the presence of symptom- free intervals after the sequence mania-depression or depression-mania. Method: The study sample includes 140 consecutive patients with bipolar I or II disorder according to DSM-IV criteria, aged 18-65 years and receiving prophylactic treatment for ?1 year. Treatment was based upon international guidelines and clinical experience at the time of patient?s enrollment (from January 1998 to January 2006). Primary outcome was the absence of new episodes during the follow-up. Significance level was set at p<.05

Biography :

Rocco de Filippis completed his MD and PhD from Catholic University of the Sacred Heart in Rome. Investigator Meeting (Western Europe and North America) per il BRENDA/Studio di fase II farmacologico sul Nalmefene (LUNDBECK - pharmaceutical company). Barcelona (Spain) . He holds a Master?s degree and he improved respectively in Bipolar Disorders and Addictive behavior in the years 2011/2012. He currently works at the Institute of Psychopathology - Rome as a Psychiatrist and Addictive Medicine, and up to now he represented as scientific coordinator of CME and Master of Addictive Behaviors; he currently publishes on Bipolar Disorders with high specialization on rapid cycling; he is also an official candidate at the Psychoanalytic Italian Society of the First Italian Center of Rome, and member of IPSO (International Psychoanalytic Studies Organization). He had a oral speech at Translational Medicine 2014 in Las Vegas on QTc Prolongation and Psychotropic Drugs.